Patients’ Advocates Seek Life-Saving Generic Hepatitis C Drugs

patients’ advocates have launched legal challenges to patents on hepatitis C drugs in India and Argentina, saying pharmaceutical companies are profiting from monopoly prices that leave millions unable to afford life-saving medications. In a statement, Médecins Sans Frontières, or Doctors Without Borders, said, “There are 80 million people worldwide living with hepatitis C, and we need a wide range of combination treatments available at an affordable price. With patents blocking generic competition, treatment remains prohibitively expensive in many countries.”

— source


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s